Il Dong Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 1.76%

Il Dong Pharmaceutical Co Ltd (249420) has an Asset Resilience Ratio of 1.76% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Il Dong Pharmaceutical Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

₩10.11 Billion
≈ $6.85 Million USD Cash + Short-term Investments

Total Assets

₩573.88 Billion
≈ $388.91 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Il Dong Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See Il Dong Pharmaceutical Co Ltd net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Il Dong Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Il Dong Pharmaceutical Co Ltd.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩10.11 Billion 1.76%
Total Liquid Assets ₩10.11 Billion 1.76%

Asset Resilience Insights

  • Limited Liquidity: Il Dong Pharmaceutical Co Ltd maintains only 1.76% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Il Dong Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Il Dong Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 3.73%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Tasly Pharmaceutical Group Co Ltd
SHG:600535
Drug Manufacturers - Specialty & Generic 9.09%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.02%
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
Drug Manufacturers - Specialty & Generic 0.01%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%

Annual Asset Resilience Ratio for Il Dong Pharmaceutical Co Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Il Dong Pharmaceutical Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 2.14% ₩12.61 Billion
≈ $8.54 Million
₩589.04 Billion
≈ $399.19 Million
-2.44pp
2023-12-31 4.58% ₩28.02 Billion
≈ $18.99 Million
₩611.26 Billion
≈ $414.24 Million
+0.53pp
2022-12-31 4.06% ₩26.60 Billion
≈ $18.03 Million
₩655.81 Billion
≈ $444.43 Million
+1.36pp
2021-12-31 2.69% ₩19.09 Billion
≈ $12.94 Million
₩708.97 Billion
≈ $480.46 Million
+2.59pp
2020-12-31 0.10% ₩600.00 Million
≈ $406.61K
₩605.28 Billion
≈ $410.19 Million
-0.08pp
2019-12-31 0.18% ₩1.10 Billion
≈ $748.05K
₩612.72 Billion
≈ $415.23 Million
-0.12pp
2018-12-31 0.30% ₩1.70 Billion
≈ $1.15 Million
₩564.67 Billion
≈ $382.67 Million
+0.23pp
2017-12-31 0.07% ₩376.06 Million
≈ $254.85K
₩564.63 Billion
≈ $382.64 Million
+0.05pp
2016-12-31 0.01% ₩71.17 Million
≈ $48.23K
₩550.35 Billion
≈ $372.97 Million
--
pp = percentage points

About Il Dong Pharmaceutical Co Ltd

KO:249420 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$565.84 Million
₩834.97 Billion KRW
Market Cap Rank
#11904 Global
#373 in Korea
Share Price
₩26500.00
Change (1 day)
-3.11%
52-Week Range
₩11430.00 - ₩44300.00
All Time High
₩75500.00
About

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central n… Read more